Millennium Management’s Oncolytics Biotech ONCY Stock Holding History

Millennium Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-40,887	Closed	-$43.3K	–	6351
2024 Q1	$43.3K	Sell	40,887 -86,955	-68%	-$97.2K	﹤0.01%	5704
2023 Q4	$173K	Sell	127,842 -85,181	-40%	-$133K	﹤0.01%	5223
2023 Q3	$464K	Buy	+213,023	New	+$520K	﹤0.01%	4708
2023 Q1	–	Sell	-25,689	Closed	-$42K	–	6715
2022 Q4	$42K	Buy	+25,689	New	+$39K	﹤0.01%	5839
2018 Q4	–	Sell	-46,563	Closed	-$180K	–	4062
2018 Q3	$180K	Sell	46,563 -442,968	-90%	-$2.06M	﹤0.01%	3662
2018 Q2	$2.69M	Buy	+489,531	New	+$3.01M	﹤0.01%	2204

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Millennium Management's ONCY Position: Q2 2024 in Review

Millennium Management sold out of Oncolytics Biotech (ONCY) in Q2 2024, closing a stake of 40,887 shares — an estimated $43.3K sold.

Millennium Management first reported a position in ONCY in Q2 2018 and held it in 6 quarters. The position peaked at $2.69M in Q2 2018. 41 funds tracked by Wall St. Rank hold ONCY as of Q2 2024.

Millennium Management reported no remaining Oncolytics Biotech position as of Q2 2024 after selling out during the quarter.
Millennium Management sold 40,887 Oncolytics Biotech shares in Q2 2024, an estimated $43.3K.
Millennium Management first reported a position in Oncolytics Biotech in Q2 2018 and held it in 6 quarters.
Millennium Management's Oncolytics Biotech position peaked at $2.69M in Q2 2018.
41 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.